How to Negotiate Your First Term Sheet

Understanding the Term Sheet: What You're Really Negotiating

A term sheet is the investor's proposal for funding. It includes: valuation (what's the company worth), investment amount (how much money), terms (liquidation preference, anti-dilution, board control, protective provisions). Most founders focus entirely on valuation. "They want to invest at $10M, I want $12M." But the truth is more nuanced. A $10M valuation with 1x non-participating liquidation preference is very different from a $12M valuation with 2x participating preference with full ratchet anti-dilution. Use our test your fundraising readiness to put this into practice.

The headline valuation drives dilution but not ultimate economics. A lower valuation with favorable terms can be better than a higher valuation with unfavorable terms. Learn to read term sheets carefully.

The Key Terms of a Term Sheet

Key terms include: (1) Post-money valuation: What value does investor assign to the company. (2) Investment amount: How much cash the investor puts in, (3) Liquidation preference: Whether preferred stock gets paid first on exit, 1x, 2x, multiple, (4) Anti-dilution: How investors are protected if later rounds have lower valuation, (5) Board composition: How many board seats founder/investor get, (6) Protective provisions: What decisions require investor approval, (7) Drag-along rights: Can majority force minority to sell. (8) Information rights: What financial reporting investor requires.

Valuation Negotiation: Finding Your Walk-Away Number

Before you negotiate, determine your walk-away number. Below that valuation, you don't accept the deal. This depends on your metrics and alternatives. A company with $500K ARR and strong growth might walk away below $8M. A company with $100K ARR and unproven product might walk at $3M. Know your number. You need conviction to walk away.

When investor proposes $8M and you want $12M, don't immediately counter at $12M. Ask why they proposed $8M. "Our model assumes 25% annual growth. At $500K ARR growing 25%, we project $1.6M ARR in 3 years. At a 5x multiple on $1.6M ARR, the company should be worth $8M in 3 years. Discounted back, current valuation is $8M." Now you understand their logic. You might counter: "We project 50% annual growth, which gets us to $3.4M ARR in 3 years, worth $17M at a 5x multiple. Current valuation should be $12M." You're arguing about growth assumptions, not pulling numbers from air.

Liquidation Preference: The Make-or-Break Term

Liquidation preference is where term sheet negotiations get real. A 1x non-participating preference is founder-friendly. A 2x participating with full ratchet anti-dilution is investor-friendly and can eliminate founder returns in down scenarios. Negotiate hard on this term because it affects your downside.

Acceptable preferences: (1) 1x non-participating is standard and fair, (2) 1x participating is slightly investor-favorable but acceptable if everything else is good. (3) 2x non-participating is unusually investor-favorable; push back unless you have no alternatives. (4) 2x participating is too investor-favorable; walk away if investor insists.

Anti-Dilution: Full Ratchet vs Weighted Average

Full ratchet anti-dilution is a deal killer. If you agree to full ratchet, a down-round (Series B at lower valuation) will massively dilute you. Example: Series A at $10M, you own 20%. Series B at $6M with full ratchet anti-dilution gives Series A enough shares to maintain 20% ownership, diluting your ownership dramatically. Avoid it.

Weighted average is standard and acceptable. It provides some investor protection without destroying founder equity. Negotiate for "broad-based" weighted average (includes options in denominator) rather than "narrow-based" (only issued shares). If investor insists on narrow-based, you've agreed to more downside dilution, but at least it's better than full ratchet.

Board Composition: Who Controls?

Series A typically gives investors one board seat. With you (founder/CEO) and them, it's 2 seats. If you add a board chair (often a neutral party), it's 3 seats. A well-balanced board is CEO (you) + 1 investor seat + 1 independent seat = 3 seats total, with each party having 1. This gives neither side control.

Push for founder majority if possible. 3 seats: CEO + 1 ally seat (existing investor, advisor, or independent aligned with you) + 1 investor seat = founder majority. Or 5 seats: CEO + 1 ally + 1 investor + 2 independent seats. As long as you have majority or tie-breaking vote, you maintain control. Investors will push for more seats, especially if the founder is inexperienced or they have significant ownership (30%+).

Protective Provisions: Limiting Investor Veto Rights

Protective provisions are veto rights over specific decisions. Common ones: can't raise new senior securities, can't declare dividends, can't change preferred stock terms, can't sell the company. These are reasonableinvestors should have some protections. But negotiate hard on the scope. Should they have veto over hiring the CFO? Probably not. Over raising a new round? Yes. Over selling the company for less than X amount? Maybe.

Limit protective provisions to high-impact decisions: raising new senior securities, selling the company, material changes to business. Avoid provisions about hiring, budget, product direction, or other operational matters.

Information Rights and Financial Reporting

Investors will require quarterly financial reports and annual audits (usually after Series B). Monthly reporting is overkill and expensive, but quarterly is standard. Agree to quarterly P&L, balance sheet, cash flow, and board updates. Resist demands for monthly reporting until later rounds. Resist demands for real-time information access (investors shouldn't have dashboard access to your accounting system).

Negotiation Strategy: The Back-and-Forth

When you receive a term sheet, you don't immediately accept or reject. You negotiate. Investor sends term sheet with proposed terms. You counter with a marked-up version requesting changes. They push back on some items, concede on others. This cycle continues until you reach agreement or decide it's not a fit.

Prioritize what matters to you. Valuation matters but not as much as you think. Liquidation preference matters hugely. Anti-dilution matters. Board control matters. Information rights matter less. Let investor win on smaller items (they get information rights they want, you care less) and win on big items (you get favorable liquidation preference). This gives investor the feeling they "won" while you actually won the important stuff.

The Power of Walking Away

Your best negotiation power is willingness to walk away. If you seem desperate to accept any deal, investor will push for unfavorable terms. If you're willing to walk away and raise from someone else, you have leverage. Have multiple investors interested, and your leverage increases. Have just one interested, and you're in a weak negotiating position.

That said, walking away when you only have one interested investor is riskyyou might raise from nobody. The balance is: know your walk-away terms (valuation, liquidation preference, board control), try to negotiate them, be willing to walk if investor won't budge, but also be realistic about your alternatives. If this is your only investor and their terms aren't totally unreasonable, taking the deal might be your best option.

Common Mistakes Founders Make During Fundraising

The most expensive fundraising mistake is starting too late. Most founders begin outreach when they have 3-4 months of runway, which means they are negotiating from a position of desperation rather than strength. The rule of thumb: start fundraising when you have 9-12 months of runway, which gives you time to be selective, build relationships before asking, and walk away from bad terms.

The second most common mistake is treating all investors as interchangeable. A $1M cheque from a generalist angel who does not understand your space is materially less valuable than the same cheque from a domain-expert who can open doors, advise on hiring, and provide credibility with the next round's investors. Spend time mapping which investors have backed comparable companies and who can genuinely add value beyond capital.

Sharing your financial model too early before you understand what narrative it supports is another frequent error. Investors will poke at your assumptions; if you have not stress-tested your own model, you will be caught flat-footed. Run your own sensitivity analysis before sharing. Know which assumptions drive the outcome, which are defensible, and which are genuinely uncertain and why you have chosen your specific estimate.

Finally, many founders fail to maintain competitive tension. Investors move faster when they know others are interested. Running a tight, parallel process meeting multiple investors in the same 4-6 week window is not rude; it is expected professional behaviour. Telling an investor you have other conversations at a similar stage is appropriate; it signals that the opportunity is competitive.

What Investors Are Actually Evaluating

Early-stage investors particularly pre-seed and seed are making a bet on the team before there is sufficient evidence to bet on the business. The three questions they are answering are: can this team build what they say they are building, can they sell it, and can they raise again? Everything in your pitch, your data room, and your financial model feeds these three questions.

At Series A, the emphasis shifts toward evidence of product-market fit and the beginnings of repeatable unit economics. Investors at this stage want to see cohort data showing retention, CAC by channel broken out from blended numbers, NRR above 100% for SaaS, and a clear model for how spending $X in sales and marketing generates $Y in predictable ARR.

Soft signals matter too. Responsiveness, clear communication, and handling difficult questions well all feed into an investor's assessment of whether they want to work with this team for the next 7-10 years. Founders who over-explain, become defensive about their model, or cannot answer basic questions about their own business quickly undermine confidence.

Worked Example

A concrete example clarifies what the mechanics actually mean in practice. Take a startup raising a $2M seed round at a $10M pre-money valuation. Post-money is $12M. The investors receive 16.7% of the company ($2M / $12M). If the founders started with a 10M share option pool and no previous investors, the post-round cap table might look like: Founder A 42%, Founder B 28%, Employee option pool 13.3%, Seed investors 16.7%.

Now add a SAFE from 18 months earlier: $500K at a $5M cap. When the seed round closes at a $10M pre-money valuation, the SAFE converts at the $5M cap which means it converts at the more favourable price ($5M cap / shares outstanding) not the current round price. The SAFE holder receives 2x as many shares per dollar as the new seed investors, because the cap protects them. This dilutes the founders more than a simple calculation of the seed round would suggest.

Running a fully diluted cap table including all SAFEs, convertible notes, and the fully vested option pool before you price a new round is essential. Many founders are surprised by how much dilution accumulated SAFEs and notes represent. A cap table model that updates automatically when you enter new round terms is worth building before you enter any serious fundraising conversation.

Frequently Asked Questions

How much detail should my financial model include?

Enough to demonstrate that you understand your unit economics and cost structure, but not so much that navigating the model requires a manual. The test: can an investor who has never seen your business understand the key assumptions and how they drive the output within 10 minutes? If yes, the model has the right level of detail. Build the complexity behind the scenes if you need it; present the clarity on the surface.

When should I share my financial model with investors?

Share the model after a first meeting has gone well and there is clear interest. Sending your full model as part of an initial cold outreach buries the key insights in complexity. Lead with the summary metrics (ARR, growth rate, burn, runway, NRR) in the deck; share the full model when an investor asks, which signals real engagement.

How do investors check whether my projections are credible?

They benchmark against comparable companies at your stage, check the internal consistency of your model (does headcount scale sensibly with revenue, do COGS move in the right direction with volume), and stress test the key assumptions. The question they are asking is not "will these exact numbers come true" they know they will not but "does this team think rigorously about their business and understand what drives it?"

What is the biggest red flag in a startup's financials?

Inconsistency between what founders say and what the numbers show. If the pitch says strong retention but the cohort data shows declining NRR; if the growth narrative is compelling but the CAC data shows customer acquisition is getting harder and more expensive; if the gross margin story is software-like but the actual margin is 45% because of significant services delivery these gaps between narrative and data destroy credibility quickly.